Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2017, Article ID 4263017, 10 pages
https://doi.org/10.1155/2017/4263017
Research Article

Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes

1Department of Ophthalmology, Centro Hospitalar São João, Porto, Portugal
2Department of Sense Organs, Faculty of Medicine of the University of Porto, Porto, Portugal
3Department of Anatomy, Faculty of Medicine of the University of Porto, Porto, Portugal

Correspondence should be addressed to Ana Catarina Pedrosa; moc.liamg@asordep.c.aniratac

Received 6 December 2016; Revised 7 March 2017; Accepted 19 March 2017; Published 1 June 2017

Academic Editor: Siamak Ansari-Shahrezaei

Copyright © 2017 Ana Catarina Pedrosa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [7 citations]

The following is the list of published articles that have cited the current article.

  • Sidsel Ehlers Klug, and Toke Bek, “Age, sex, and type of medication predict the effect of anti-VEGF treatment on central retinal thickness in wet age-related macular degeneration,” Clinical Ophthalmology, vol. 12, pp. 473–479, 2018. View at Publisher · View at Google Scholar
  • Siyang Chaili, and Sean D. Adrean, “Management Strategies and Visual Results for the Treatment of Neovascular Age-Related Macular Degeneration,” Macular Degeneration - A Glance to the Future [Working Title], 2018. View at Publisher · View at Google Scholar
  • Jae Hui Kim, Young Suk Chang, Jong Woo Kim, Chul Gu Kim, and Dong Won Lee, “Prechoroidal Cleft in Type 3 Neovascularization: Incidence, Timing, and Its Association with Visual Outcome,” Journal of Ophthalmology, vol. 2018, pp. 1–8, 2018. View at Publisher · View at Google Scholar
  • Naser Aidenloo, Mohammad Abbaszadeh, Qader Motarjemizadeh, and Vahid Sadrinia, “Intravitreal bevacizumab with or without triamcinolone for wet age-related macular degeneration: Twelve-month results of a prospective, randomized investigation,” Middle East African Journal of Ophthalmology, vol. 25, no. 1, pp. 1–7, 2018. View at Publisher · View at Google Scholar
  • A. Zh. Fursova, N. V. Chubar, M. S. Tarasov, M. A. Vasilyeva, and O. G. Gusarevich, “Anti-VEGF therapy for age-related macular degeneration,” Vestnik oftal'mologii, vol. 134, no. 6, pp. 59, 2018. View at Publisher · View at Google Scholar
  • Siyang Chaili, Hema Ramkumar, Sean D. Adrean, Ash Pirouz, and Scott Grant, “Consistent Long-Term Therapy of Neovascular Age-Related Macular Degeneration Managed by 50 or More Anti–VEGF Injections Using a Treat-Extend-Stop Protocol,” Ophthalmology, 2018. View at Publisher · View at Google Scholar
  • Mania Horani, Sajjad Mahmood, and Tariq M. Aslam, “Macular Atrophy of the Retinal Pigment Epithelium in Patients with Neovascular Age-Related Macular Degeneration: What is the Link? Part I: A Review of Disease Characterization and Morphological Associations,” Ophthalmology and Therapy, 2019. View at Publisher · View at Google Scholar